The results of combined clinical allergologic study and SHF thermography in patients with pollenosis, chronic asthmatic bronchitis, bronchial asthma, continuous and seasonal allergic rhinitis and normal controls are reported. Patients with pulmonary disorders showed a reduction by 1 degree C in mean deep temperature around the lungs, and a sevenfold increase in deep temperature dispersion, as compared to the controls. Patients with pollenosis showed a reduction of deep temperatures by 1.5-2 degrees C in the gastric area and the ascending intestinal portion. In patients with allergic rhinitis, the temperature differences between the tip of the nose and maxillary sinuses, typical for normal subjects, become insignificant. Possible mechanisms of the demonstrated temperature abnormalities are discussed. The data obtained are compared to those obtained by means of IR thermography in the same categories of patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patients pollenosis
8
allergic rhinitis
8
deep temperature
8
patients
5
[shf-thermography allergic
4
allergic diseases]
4
diseases] combined
4
combined clinical
4
clinical allergologic
4
allergologic study
4

Similar Publications

Pollinosis is the most prevalent allergic disorder. Assessing the impact of real-world pollen exposure on symptoms remains challenging due to extensive patient-level efforts required. This study explores the potential of wastewater-based epidemiology (WBE) to investigate the relationship between airborne pollen concentrations and antihistamine residues in wastewater as an indicator of pollinosis symptom treatment at the population-scale.

View Article and Find Full Text PDF

Introduction: To date, no investigations have been published regarding the concentration, dose, and technique for a mucosal spray application of botulinum toxin A (BTA) to alleviate hypersecretory symptoms of rhinitis in humans. It is a promising option for reducing common symptoms of seasonal allergic rhinitis (AR) and idiopathic non-AR. It is safer and less painful than intranasal injections, with high reported satisfaction in reducing clinical symptoms.

View Article and Find Full Text PDF

Prednisolone versus antihistamine for allergic rhinitis: No significant difference found in randomized trial.

Clin Transl Allergy

January 2025

Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Background: Seasonal allergic rhinitis (AR) impacts public health by affecting work productivity and quality of life. The Swedish tree pollen season starts in February with alder and hazel pollination, followed by birch and ends with oak in May. Systemic corticosteroids are often prescribed when topical treatments fail, despite limited evidence supporting their efficacy.

View Article and Find Full Text PDF

Immunoproteomic analysis and identification of possible allergenic proteins in Artemisia annua pollen.

Int Immunopharmacol

January 2025

School of Pharmacy, Ningxia Medical University, 1160 Shenli Street, Yinchuan 750001, China. Electronic address:

Background: Artemisia annua (A. annua) is a wind-pollinated weed and a major allergen responsible for allergic respiratory diseases in Northern China.

Methods: This study involved the separation of pollen proteins from A.

View Article and Find Full Text PDF

Airborne pollen is considered to be one of the air pollutants that can cause allergic reactions in humans, leading to the occurrence or aggravation of a series of allergic diseases. The latest study showed that the positive rate of pollen allergens in allergic rhinitis patients in urban areas of Beijing exceeded 80%. Accurate prediction of pollen content could provide more effective assistance to susceptible populations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!